Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: PDT

1health Streamlines Rapid Test Results for Healthcare Providers and Employers

SAN FRANCISCO, Dec. 2, 2021 /PRNewswire/ -- 1health, a leading cloud platform for modern diagnostic test management and pioneer of COVID-19 risk mitigation solutions, today announced the release of its newest offering, ResultShare, a powerful cloud-based platform designed to solve the deployment, tracking, and integration of results for rapid test devices.

1health introduces the ResultShare platform to enable secure and compliant sharing of rapid diagnostic test results.

As the COVID-19 pandemic progresses, employers and healthcare providers are looking for uncomplicated ways to efficiently implement testing and prevention strategies to safeguard their populations. Rapid Over the Counter (OTC) or Point of Care (POC) diagnostic tests offer a simple solution, but challenges with capturing and sharing results with the appropriate parties have slowed adoption.

1health, in partnership with healthcare providers, rapid test manufacturers, and enterprise partners, is now releasing the revolutionary ResultShare platform. ResultShare empowers test device manufacturers and distributors to better reach and serve their growing customer base by enabling simple registration, easy result capture & seamless system integrations.

Through the 1health solution, patients are able to register and capture test results in a few, simple steps. Results are uploaded to a secure health cloud where enterprises or healthcare providers can easily access them - pending the patient's approval. The solution can be applied to virtually any rapid test device and designed for an easy, seamless launch. Further, any organization or provider with the appropriate permissions may access the health cloud, making it easy for device manufacturers to leverage ResultShare for both existing customers and new business.

"Effectively managing the COVID pandemic is in part dependent on the integration of rapid test information into digital compliance databases, which has thus far been a barrier in the adoption of rapid testing across the country," said Al Hariri, COO of 1health. "At 1health, we are committed to continued partnership with device manufacturers and distributors to ensure that through our new ResultShare platform, we can promote more widespread usage of these critical diagnostic test devices."

The ResultShare platform builds on the 1health standard of delivering innovative integrations and interfaces that help labs and their customers make clinical testing more accessible and impactful. 1health was also a pioneer in developing and releasing COVID-19 testing and vaccine verification services, allowing companies across the country to safely bring their workforces back onsite. To learn more about ResultShare and other 1health COVID-19 initiatives, visit learnmore.1health.io/ResultShare.

About 1health
At 1health, we're committed to making diagnostic testing easy and accessible by building the infrastructure that helps labs- and their customers- connect patients to testing and care. Our powerful platform provides end-to-end solutions to help labs streamline their processes, expand their capabilities, and enhance their accessibility while our flexible APIs enable lab customers to drive better patient engagement and compliance through uniquely accessible and impactful solutions.

To learn more, visit 1health.io.

Media Contact:
Lindsay Hilbelink

SOURCE 1health

These press releases may also interest you

at 04:00
Based in Augusta, Georgia, USA, Jinfiniti Precision Medicine is dedicated to increasing human health and lifespan by providing a range of rapid screening services to biomedical research institutions, nutraceutical companies, the longevity industry,...

at 04:00
The Celiac Disease Foundation, the nation's leading patient advocacy organization for celiac disease, announces its newest appointee, Casey Guber, to its Board of Directors. The officers for 2022 are Chair Adrienne Bender, Vice Chair John Wagner,...

at 03:46
Mentice AB (STO: MNTC) announces that the company will present its year-end report via a webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the...

at 03:41
Apollon Formularies plc (AQSE: APOL) ("Apollon" or the "Company"), a UK based international medical cannabis pharmaceutical company trading on AQSE Growth Market, is pleased to announce the appointment of Dr. Herbert Fritsche to the Board of...

at 03:01
Nova Mentis Life Science Corp. ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is proud to announce that the Company...

at 03:00
SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has appointed Professor Michael J. Econs, MD as Clinical Advisor. Distinguished Professor of Medicine and Medical and Molecular Genetics at...

News published on 2 december 2021 at 12:39 and distributed by: